88IV - PR Newswire Asia's news


Insilico Medicine Launches the Industry's First Drug Discovery and Development (DDD) Benchmark as a Service, to Evaluate Frontier AI and Foundation Models on Real-World Science Leveraging 30+ validated PCC programs and over 12 years of model development experience to create a large-scale real-world "blind test" for frontier AI and foundation models, with a transparent ... 2026-07-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Continuity Biosciences Appoints Vicky Papoutsis to Board of Directors Business development and corporate strategy executive joins Board as Company advances its clinical programs and partnering activity ... 2026-07-30T Biotechnology Health Care/Hospital
NMPA Accepts New Indication Application for Sacituzumab Tirumotecan (sac-TMT) as First-Line Treatment for Advanced TNBC CHENGDU, China , July 30, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that a new indication application ... 2026-07-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Propel Health Australia Highlights Emerging Research into Fulvic Acid and Microplastics BRISBANE, Australia , July 30, 2026 /PRNewswire/ -- Propel Health is highlighting new laboratory research published in Science of the Total Environment showing that fulvic acid can interact ... 2026-07-30T Biotechnology Health Care/Hospital
Piramal Pharma Limited Announces Results for Q1 FY27 MUMBAI, India , July 30, 2026 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated ... 2026-07-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ractigen Therapeutics Closes Over $31 Million Financing to Advance Clinical-Stage saRNA Pipeline and Proprietary Extrahepatic Delivery Platforms Funding led by Guozhong Capital will accelerate Phase 2 development for saRNA candidate RAG-01 and CNS asset RAG-17, advance systemic saRNA program RAG-18 toward IND, and expand extrahepatic RNA delivery ... 2026-07-29T Banking/Financial Service Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Insilico Medicine Receives FDA Fast Track Designation for ISM6331, the AI-driven Pan-TEAD Inhibitor, in Advanced Mesothelioma FDA Fast Track Designation (FTD) aims to accelerate the review process of high-value assets, and ISM6331 marks Insilico's first FTD, recognizing the clinical potential in advanced mesothelioma. ISM6331 ... 2026-07-29T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Sorona® and WGSN Announce Top Bio-Based Material Trends of 2027 Bio-based materials emerge as a leading trend shaping the future of fashion across athleisure and luxury ready-to-wear apparel ... 2026-07-29T Biotechnology Fashion Household/Consumer/Cosmetics Textiles
AbbVie Announces Availability of ELAHERE® (mirvetuximab soravtansine) in Singapore for the Treatment of Platinum-Resistant Ovarian Cancer ELAHERE is the first and only antibody-drug conjugate (ADC) therapy approved specifically for patients with folate receptor alpha (FRα) positive, platinum-resistant high grade serous epithelial ovarian ... 2026-07-29T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ozelle Launches O-Cyte 1 at ADLM 2026, Marking a New Step in AI-Powered Hematology The global launch brings image-based morphology intelligence into routine hematology workflows through AI × CBM technology. ... 2026-07-29T Biotechnology Health Care/Hospital Medical Equipment

PR Newswire Asia's news > Biotechnology